Roy Moore, DRG’s Principal Director of Global Market Access Insights, presents an overview of the healthcare effects of the 2016 U.S. election. Joined by industry analysts focused on various aspects of the healthcare ecosystem, Roy examines the implications of Republican control of national healthcare policy for the first time in a decade. Touching on the potential impact for the pharmaceutical and medical device industries, DRG experts share their assessment of what shifting policies may mean for the industry.

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now